SANES

10.488

-0.11%↓

BBVA

19.37

+0.83%↑

BNP

89.93

+0.95%↑

CABK

11.445

+0.35%↑

INGA

26.45

+1.24%↑

SANES

10.488

-0.11%↓

BBVA

19.37

+0.83%↑

BNP

89.93

+0.95%↑

CABK

11.445

+0.35%↑

INGA

26.45

+1.24%↑

SANES

10.488

-0.11%↓

BBVA

19.37

+0.83%↑

BNP

89.93

+0.95%↑

CABK

11.445

+0.35%↑

INGA

26.45

+1.24%↑

SANES

10.488

-0.11%↓

BBVA

19.37

+0.83%↑

BNP

89.93

+0.95%↑

CABK

11.445

+0.35%↑

INGA

26.45

+1.24%↑

SANES

10.488

-0.11%↓

BBVA

19.37

+0.83%↑

BNP

89.93

+0.95%↑

CABK

11.445

+0.35%↑

INGA

26.45

+1.24%↑

Home・Elenco Azioni・Sartorius Stedim Biotech.

Sartorius Stedim Biotech.

Chiusa

SettoreFinanza

171 -0.47

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

170.5

Massimo

174.3

Metriche Chiave
By Trading Economics
Entrata	41M 88M
Vendite	-11M 762M
P/E Media del settore	57.428 58.236
EPS	1.17
Margine di Profitto	11.569
Dipendenti	10,456
EBITDA	26M 225M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+36.9% upside

Dividendi
By Dow Jones
Utili prossimi	23 lug 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-2.7B 15B
Apertura precedente	171.47
Chiusura precedente	171

Notizie sul Sentiment di mercato

By Acuity

92%

3 / 438 Classifica in Finance

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

202.7 / 211.7 Supporto e resistenza

Sartorius Stedim Biotech. Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

22 mag 2026, 16:33 UTC

Utili

I principali Market Mover

Webull Shares Slide on 1Q Loss, Soaring Costs

22 mag 2026, 21:10 UTC

Utili

These Stocks Are Today's Movers: Dell, Apple, IBM, Estée Lauder, Futu, Rocket Lab, Workday, and More -- Barrons.com

22 mag 2026, 20:50 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

22 mag 2026, 20:50 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Financial Services Roundup: Market Talk

22 mag 2026, 20:50 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

22 mag 2026, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

22 mag 2026, 19:47 UTC

Utili

Nvidia Has a Plan to Get the Stock Moving Again -- Barrons.com

22 mag 2026, 19:17 UTC

Discorsi di Mercato

U.S. Natural Gas Retreats As Weather Outlook Cools -- Market Talk

22 mag 2026, 19:10 UTC

Discorsi di Mercato

Oil Futures Edge Up Ahead of U.S. Long Weekend -- Market Talk

22 mag 2026, 18:54 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

22 mag 2026, 18:54 UTC

Discorsi di Mercato

Kroger Seen Narrowing Pricing Gap Versus Walmart -- Market Talk

22 mag 2026, 18:38 UTC

Discorsi di Mercato

Canada's Population Slowdown Hits Demand for Consumer Companies -- Market Talk

22 mag 2026, 18:35 UTC

Acquisizioni, Fusioni, Takeovers

IMAX Might Be Exploring a Sale. Who Could Be Buying. -- Barrons.com

22 mag 2026, 18:09 UTC

Discorsi di Mercato

Centralized Crypto Lending Slows in 1Q -- Market Talk

22 mag 2026, 17:58 UTC

Discorsi di Mercato

U.S. Oil Rig Count Shows Signs of Picking Up -- Market Talk

22 mag 2026, 17:54 UTC

Discorsi di Mercato

Market Talk Roundup: Latest on U.S. Politics

22 mag 2026, 17:54 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

22 mag 2026, 17:54 UTC

Discorsi di Mercato

Canada Minister May Be Distancing From Online-Streaming Order -- Market Talk

22 mag 2026, 17:03 UTC

Discorsi di Mercato

Canada Spending Obligations on Streamers Is More Severe Beneath Surface -- Market Talk

22 mag 2026, 16:54 UTC

Discorsi di Mercato

Crypto Spot Volumes Fall 14% in April -- Market Talk

22 mag 2026, 16:20 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Financial Services Roundup: Market Talk

22 mag 2026, 16:20 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

22 mag 2026, 16:20 UTC

Discorsi di Mercato

Energy & Utilities Roundup: Market Talk

22 mag 2026, 16:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

22 mag 2026, 16:16 UTC

Discorsi di Mercato

TSX Growth Driven Almost Entirely by Materials Sector -- Market Talk

22 mag 2026, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

22 mag 2026, 15:55 UTC

Discorsi di Mercato

Trump Admin Grants Reinforce IBM's Quantum Computing Leadership -- Market Talk

22 mag 2026, 15:42 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

22 mag 2026, 15:42 UTC

Discorsi di Mercato

Oil Continues as Leading Indicator for All Markets -- Market Talk

22 mag 2026, 15:35 UTC

Discorsi di Mercato

Gas Prices May Limit Spread of Inflationary Pressures in Canada -- Market Talk

Confronto tra pari

Modifica del prezzo

Sartorius Stedim Biotech. Previsione

Obiettivo di Prezzo

By TipRanks

36.9% in crescita

Previsioni per 12 mesi

Media 233 EUR 36.9%

Alto 262 EUR

Basso 210 EUR

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Sartorius Stedim Biotech. - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

8 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 8 che hanno fornito valutazioni azionarie a Sartorius Stedim Biotech. - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

202.7 / 211.7Supporto e resistenza

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

3 / 438 Classifica in Finanza

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.